Sleep Apnea Failure
In 1981, at the University of Sydney, Colin Sullivan and colleagues described and developed nasal continuous positive airway pressure (CPAP),this noninvasive treatment for obstructive sleep apnea (OSA) is quite successful.
Sullivan, who had patented the technology, hepublicized the initial successful results in Lancet, and attempted to find a compatible partner to help commercialize the sleep technology. Chris Lynch, who was then working with Dr. Peter Farrell, who was Vice President of R&D for Baxter Healthcareand alsoManaging Director of the Baxter Centre for Medical Research, Japan, met with Sullivan and recommended that Peter also meet with him to hear his story in 1986,. In 1987,the result was that Farrell, on behalf of Baxter, invested
Sullivan, who had patented the technology, hepublicized the initial successful results in Lancet, and attempted to find a compatible partner to help commercialize the sleep technology. Chris Lynch, who was then working with Dr. Peter Farrell, who was Vice President of R&D for Baxter Healthcareand alsoManaging Director of the Baxter Centre for Medical Research, Japan, met with Sullivan and recommended that Peter also meet with him to hear his story in 1986,. In 1987,the result was that Farrell, on behalf of Baxter, invested